Bureau of Health Emergency Management
HAN Alerts
2024
- Highly Pathogenic Avian Influenza identified in New Mexico Cattle and Texas Resident-April 4,2024
- Update for Clinicians on Testing, Treatment, and Vaccination for Monkeypox (MPOX) - March 18,2024
- Increasing Incidence of Measles - March 5, 2024
- CDC Recommends Additional Updated COVID-19 Dose for Older Adults - February 29, 2024
2023
- New Mexico Data Show Opportunity to Improve High-dose Influenza Vaccination for Patients 65 years and Older
- Immunization Coverage for Influenza, COVID-19 and Use of Authorized/Approved Therapeutics
- CDC Advisory - High Blood Lead Levels in Children Consuming Recalled Cinnamon
- Protecting Infants from RSV during the National Nirsevimab (Beyfortus) Shortage
- New Mexico Department of Health Announces Start of Influenza (Flu) Season 2023-2024
- Recommendation for Expanded Syphilis Screening to Reduce Rising Rates of Congenital Syphilis
- Outbreak of Cryptosporidiosis Associated with Exposure to the State Fair
- New Mexico Department of Health Seeks Clinician Enrollment in ILINet
- CDC and FDA Recommend Updated (2023-2024) COVID19 Vaccines
- Doxycycline Post-Exposure Prophylaxis (doxy-PEP) for the Prevention of Sexually Transmitted Infections
- COVID-19 Update - Paxlovid Prescribing - August 24, 2023
- Increased Numbers of West Nile Cases in New Mexico in 2023 - August 18, 2023
- New HIV infections associated with former VIP Spa in Albuquerque - June 26, 2023
- Increased Numbers of Hantavirus Cases in New Mexico in 2023 - May 24, 2023
- Updated SARS-CoV-2/COVID-19 Test Result Reporting Instructions
- Drug Shortage of Bicillin L-A® for the Treatment of Syphilis
- New Mexico Department of Health Marks the End of the 2022-2023 Influenza Season
- CDC and FDA Update COVID-19 Vaccine Schedule
- Xylazine-related Overdose Warning
- Ongoing Drug-Resistant Shigella Infections in Albuquerque Area
- Ezri Care Artificial Tears Recall
- Clusters of Carbapenem Resistant Pseudomonas aeruginosa Eye Infections In Multiple States
2022
- NMHAN CDC Advisory: Prioritize Antivirals for Influenza
- Drug Shortage Alert- Pediatric Antipyretics and Amoxicilin
- CDC and FDA Authorize COVID19 Bivalent Vaccine for Youngest Children - 12/12/2022
- COVID-19 Therapeutics Update: Bebtelovimab & Evusheld Pause - 11/18/2022
- Increased Respiratory Activity - 2022-23 Season
- Congenital Syphilis - 10/05/2022
- First confirmed Candida auriscase in NM - 10/05/2022
- Adverse Child Experiences in New Mexico 10-11-2022
- Outbreak of Ebola virus disease (Sudan ebolavirus) in Central Uganda - 10/06/2022
- UNM Capacity- 09/16/2022
- RV-EV Respiratory Illness
- HAN Flu Vaccination Reccomendations
- Acute Flaccid Myelitis and Polio - 09/16/2022
- CDC and FDA Authorize COVID19 Bivalent Vaccine for Boosters - 09/05/2022
- Mpox Update - 08/09/2022
- Paxlovid - 07/19/2022
- Mpox Virus Infection in the United States and Other Non-endemic Countries - 07/08/2022
- New Mexico Department of Health (NMDOH) Marks the End of the 2021-2022 Influenza Season
- Measles Case in Santa Fe County, NM
- Mpox Virus Infection in the United States and Other Non-endemic Countries - 05/26/2022
- COVID-19 Therapeutics Update: Patient Issuance of COVID-19 Therapeutic within Therapeutic Window - 05/26/2022
- Updated Booster Guidance - 05/22/2022
- Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology - 04/21/2022
- COVID-19 Vaccination Rule 3
- COVID-19 Vaccination and Treatment During Pregnancy - 04-07-2022
- Joint Statement on COVID-19 Vaccination and Treatment During Pregnancy - 04-06-2022
- COVID-19 Therapeutics Update: Sotrovimab Pause & Updated NIH Treatment Guidelines - 04-05-2022
- COVID Therapeutics - Quick Reference for Prescribers - 04-05-2022
- Pediatric Ingestion of Cannabis Products - 03-31-2022
- COVID-19 2nd Booster Dose Guidance 03-30-2022
- COVID-19 Therapeutics Update: Evusheld - 02-28-2022
- Update for Providers regarding COVID-19 & Immunocompromised Patients - 02-22-2022
- COVID -19 Dealth Risk for Select Age Groups and Comorbid Conditions - 02-16-2022
- COVID -19 Dealth Risk Increases as the Number of Comorbid Conditions Increases - 02-16-2022
- COVID-19 Therapeutics Update: Patient Eligibility Criteria & New COVID-19 Therapeutic - 02-16-2022
- COVID Therapeutics - Quick Reference for Prescribers - 02-16-2022
- Guidance for immunocompromised - 02-15-2022
- Therapeutics Update:Eligibility Criteria & Oral Antiviral & Monoclonal Antibody - 01-25-2022
- Requirements on Electronic Death Certifications - 01-24-2022
- Public Health Order Enforcement to start 2/4/2022 of Up To Date Vaccination of Status - 01-14-2022
- CDC and FDA Shorten Booster Interval for Moderna COVID-19 Vaccine - 01-10-2022
- Update on Omicron and COVID-19 Therapeutics - 01-07-2022
- CDC and FDA Update Indications for Pfizer-BioNTech COVID-19 Vaccine - 01-06-2022
- Updated Guidance on Managing Healthcare Personnel with Infection or Exposure - 01-05-2022
2021
- COVID-19 - 12-21-2020
- COVID-19 - Phase 1 A - 12-21-2020
- CDC 00438 - 12-17-2021
- Shigella In Metro Homeless - 12-16-2021
- COVID-19 Boosters for 16-17 - 12-09-2021
- COVID-19 Evusheld - mAb - 12-08-2021
- COVID-19 CDC 459 Varient Of Concern Identified - Omicron - 12-01-2021
- COVID-19 Invermectin Toxicity - 09-10-2021
- COVID-19 No Boosters Yet - 08-03-2021
- RSV Surveillance - 07-22-2021
- COVID-19 Clinical Guidance Myocarditis Following mRNA Vaccination - 06-25-2021
- COVID-19 VaST Technical Report - 06-24-2021
- COVID-19 Vaccine Data Improvement - 06-13-2021
- Sodium Citate Lab Tube Shortage - 06-06-2021
- COVID-19 Vaccine Eligibility - 06-04-2021
- NMMAT Pfizer Vaccine Recommendation 12 Years and Older - 05-13-2021
- COVID-19 Third Dose FOr Immunocompromised - 04-16-2021
- COVID-19 Pause in J&J Distribution - 04-13-2021
- Advisory Requirements For TB Testing Of HCW Resumes - 04-01-2021
- COVID-19 Pediatric Covid Testing - 02-01-2021
- Wound Botulism - 01-21-2021
- COVID-19 Non-Hospital Therapeutics Admin Application - 01-21-2021
- Wound Botulizm - 01-12-2021
2020
- Cipro Resistant Meningitidis - 08-06-2020
- Remdesivir Update Guidance - 08-28 2020
- COVID-19 Pre-Season - 09-11-2020
- COVID-19 - 09-2020
- COVID-19 - 01-16-2020
- COVID-19 - 03-31-2020
- COVID-19 -04-01-2020
- COVID-19 - Directive Reporting Testing Data on Portal - 04-03-2020
- COVID-19 - TB Testing Deferment - 04-44-2020
- COVID-19 - Releases Clinical Guidance Following VaST Technical Report - 06-25-2021
- COVID-19 - 04-20-2020
- COVID-19 - 05-06-2020
- COVID-19 - Menthol - 06-17-2020
- COVID-19 - 432 MIS-C Associated With COVID - 05-14-2020
- COVID-19 - Antibody Testing - 07-02-2020
- COVID-19 - NIH Summary - 07-28-2020
- COVID-19 - Rapid Antigen Tests - 10-16-2020
- COVID-19 - Crisis Staffing Tiers - 11-19-2020
- COVID-19 - 12-03-2020
- COVID-19 - Pfizer Vaccine Training Series For Clinicians
Other
Publications
Latest
- Highly Pathogenic Avian Influenza identified in New Mexico Cattle and Texas Resident-April 4,2024 (General)
- Update for Clinicians on Testing, Treatment, and Vaccination for Monkeypox (MPOX) - March 18,2024 (General)
- CDC Recommends Additional Updated COVID-19 Dose for Older Adults - February 29, 2024 (General)
Popular
- Paxlovid - 07/19/2022 (General)
- New Mexico Crisis Standards of Care Plan (Plan)
- All-Hazard Emergency Operations Plan (Plan)